This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

John M. Kane, MD; Arthur Rifkin, MD; Frederic Quitkin, MD; Devdutt Nayak, MD; Jorge Ramos-Lorenzi, MD

Arch Gen Psychiatry. 1982;39(1):70-73.

Abstract
• Twenty-eight patients who had recently recovered from an acute-onset, first-episode schizophrenic illness were randomly given fluphenazine hydrochloride or decanoate or placebo for a one-year period in a double-blind study. Seven of 17 patients (41%) receiving placebo experienced a psychotic relapse, whereas none of 11 drug-treated patients experienced a relapse. Eighteen (69%) of the 26 patients available for follow-up (mean interval, 3.5 years) experienced a second psychotic relapse either during the study or afterward, and 50% (14/28) of the original sample experienced a third episode.

Author Affiliations
From the Long Island Jewish-Hillside Medical Center, Glen Oaks, NY (Drs Kane, Nayak, and Ramos-Lorenzi), the Psychiatric Institute, New York (Dr Quitkin), and Mount Sinai School of Medicine, New York (Dr Rifkin).

Footnotes
Accepted for publication July 7, 1981.

Reprint requests to Long Island Jewish-Hillside Medical Center, PO Box 38, Glen Oaks, NY 11004 (Dr Kane).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Preventing the Second Episode: A Systematic Review and Meta-analysis of Psychosocial and Pharmacological Trials in First-Episode psychosis
Alvarez-Jimenez et al.
Schizophr Bull 2009;0:sbp129v1-sbp129.
ABSTRACT | FULL TEXT  

Historical perspective on antipsychotic long-acting injections
Johnson
Br. J. Psychiatry 2009;195:S7-S12.
ABSTRACT | FULL TEXT  

Clinical guideline recommendations for antipsychotic long-acting injections
Kane and Garcia-Ribera
Br. J. Psychiatry 2009;195:S63-S67.
ABSTRACT | FULL TEXT  

New-Onset Schizophrenia: Pharmacologic Treatment
Kane
Focus 2008;6:167-171.
ABSTRACT | FULL TEXT  

Unanswered Questions in Schizophrenia Clinical Trials
Kane and Leucht
Schizophr Bull 2008;34:302-309.
FULL TEXT  

Rational pharmacotherapy in early psychosis
REMINGTON
Br. J. Psychiatry 2005;187:s77-s84.
ABSTRACT | FULL TEXT  

Pharmacological Treatments for First-Episode Schizophrenia
Robinson et al.
Schizophr Bull 2005;31:705-722.
ABSTRACT | FULL TEXT  

Clinical Outcome Following Neuroleptic Discontinuation in Patients With Remitted Recent-Onset Schizophrenia
Gitlin et al.
Focus 2004;2:122-130.
ABSTRACT | FULL TEXT  

Evidence-Based Treatment for First-Episode Schizophrenia?
CARPENTER
Am. J. Psychiatry 2001;158:1771-1773.
FULL TEXT  

Clinical Outcome Following Neuroleptic Discontinuation in Patients With Remitted Recent-Onset Schizophrenia
Gitlin et al.
Am. J. Psychiatry 2001;158:1835-1842.
ABSTRACT | FULL TEXT  

Predictors of Relapse Following Response From a First Episode of Schizophrenia or Schizoaffective Disorder
Robinson et al.
Arch Gen Psychiatry 1999;56:241-247.
ABSTRACT | FULL TEXT  

Neuroleptic Withdrawal in Schizophrenic Patients: A Review of the Literature
Gilbert et al.
Arch Gen Psychiatry 1995;52:173-188.
ABSTRACT  

The Early Course of Schizophrenia and Long-term Maintenance Neuroleptic Therapy
Nuechterlein et al.
Arch Gen Psychiatry 1995;52:203-205.
ABSTRACT  

Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of Psychoses
Baldessarini et al.
Arch Gen Psychiatry 1988;45:79-91.
ABSTRACT  

Prediction of Relapse in Schizophrenia
Lieberman et al.
Arch Gen Psychiatry 1987;44:597-603.
ABSTRACT  

Low-Dose Neuroleptic Treatment of Outpatient Schizophrenics: I. Preliminary Results for Relapse Rates
Kane et al.
Arch Gen Psychiatry 1983;40:893-896.
ABSTRACT